SK Hynix Expansion Plans Halted by U.S. Export License Delays
SK Hynix's plans to expand its chip production in Dalian, China, and subsequently invest billions in new memory-chip plants in New York are facing delays. The U.S. government has not yet approved the necessary export licenses for American chipmaking equipment…
Colorado Springs Pueblo, CO, November 3, 2026 — SK Hynix, a major global semiconductor manufacturer, is experiencing significant delays with its ambitious expansion plans, impacting both its operations in China and its proposed investments in the United States. The company’s strategy hinges on the development of its chip production facilities in Dalian, China, which are intended to generate funding for substantial new memory-chip plants planned for New York.
However, the expansion in Dalian is currently stalled due to the U.S. government’s pending approval of essential export licenses. These licenses are required for SK Hynix to acquire American-made chipmaking equipment necessary for the Dalian facility’s operations. Without these licenses, the company cannot proceed with the full build-out of its Chinese production capacity.
SK Hynix has stated that the Dalian expansion is critical for securing the financial resources needed to support its multi-billion dollar investment in new memory-chip manufacturing plants in New York. This intricate financial dependency means that the delay in China directly impedes the progress of its U.S. expansion initiatives.
Details regarding the specific timeline for the export license approvals or the precise reasons for the delay have not been publicly disclosed by the U.S. government. Similarly, the exact financial figures for the planned U.S. investment, beyond being in the billions, were not provided. The contractor’s name for the Dalian facility expansion was not specified.
The outcome of the export license applications is keenly watched as it affects SK Hynix’s global manufacturing footprint and its commitment to expanding semiconductor production capacity in the United States. The company’s ability to move forward with its U.S. plants is contingent upon the successful resolution of the licensing issues for its Chinese operations.
Story summarized from the original created by Reuters on gazette.com, see more information here.
Media gallery
